The global antidiarrheals market size is expected to grow from $3.58 billion in 2021 to $3.78 billion in 2022 at a compound annual growth rate (CAGR) of 5.5%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global antidiarrheal drugs market size is expected to reach $4.39 billion in 2026 at a CAGR of 3.8%.
What is the Global Antidiarrheals Market?
The antidiarrheal drugs market consists of sale of antidiarrheal drugs and related services. Diarrhea is a disease affecting digestive parts of the body such as stomach, large intestine and rectum, esophagus, liver, gallbladder and pancreas and causes loose, watery bowel movements. Loperamide and bismuth subsalicylate are some examples of antidiarrheal drugs.
Get a Sample of the global antidiarrheals market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=3402&type=smp
What drives the Global Antidiarrheals Market?
Rise in the number of diarrhea cases significantly contributes to the growth of antidiarrheal drugs market. According to UNICEF, diarrhea was the second leading cause of death among children under the age of 5 years that is responsible for killing 760,000 children every year. Increasing number of diarrheal cases increases the demand for antidiarrheal drugs.
Get the full global antidiarrheals industry report here
https://www.thebusinessresearchcompany.com/report/antidiarrhoeals-global-market-reportGlobal Antidiarrheals Market Segments
The global antidiarrheals market is segmented:
By Drug Class: Mucosal Protectants, Motility Modifying Drugs
By Application: Adults, Children
By Type: OTC Drugs, Prescription Drugs
By Geography: The regions covered in the antidiarrheals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Antidiarrheals Global Market Report 2022provides market size and growth forecasts for the global antidiarrheals market, global antidiarrheals market share, antidiarrheals market segments and geographies, antidiarrheals market competitive landscape including leading competitors’ revenues, profiles and market shares. The antidiarrheals market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Antidiarrheals Industry Playersinclude GlaxoSmithKline, Actelion, Perrigo, Lupin and Glenmark Pharmaceuticals, Merck & Co., Pfizer, Proctor & Gamble, Sanofi Aventis and Bayer. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.